Dose: 3.5 g
Single Dose: 3.5 (3.5)
Frequency: 24 hourly
Route: oral
Instructions:

.

Polycarbophil Calcium is contraindicated in conditions like Hypersensitivity.

The severe or irreversible adverse effects of Polycarbophil Calcium, which give rise to further complications include Intestinal obstruction.The signs and symptoms that are produced after the acute overdosage of Polycarbophil Calcium include Hypersensitivity reactions.The symptomatic adverse reactions produced by Polycarbophil Calcium are more or less tolerable and if they become severe, they can be treated symptomatically, these include Abdominal distension, Flatulence.

Polycarbophil Calcium is primarily indicated in conditions like Constipation, Irritable bowel syndrome, and can also be given in adjunctive therapy as an alternative drug of choice in Diarrhoea, Hyperlipidaemia.

No data regarding the interactions of Polycarbophil Calcium was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Store in a well closed container.

There is a risk of intestinal or oesophageal obstruction and fecal impaction,esp if suchlaxatives are swallowed dry. Polycarbophil calcium should be always taken with sufficient fluid. polycarbophil calcium should not be taken by patients who have difficulty in swallowing.